查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654270

細胞分析市場規模、佔有率、趨勢分析報告：按產品/服務、方法、流程、最終用途、地區和細分市場進行預測，2025 年至 2030 年

Cell Analysis Market Size, Share & Trends Analysis Report By Product & Service, By Technique, By Process, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

細胞分析市場規模及趨勢

預計 2024 年全球細胞分析市場規模將達到 315.9 億美元，2025 年至 2030 年的複合年成長率為 10.03%。

這種成長是由慢性病的增加、細胞分析技術的進步以及藥物研發活動的增加所推動的。細胞分析已成為尋找慢性疾病潛在治療方法和治療方法的重要工具。因此，心血管疾病、癌症、自體免疫疾病和神經系統疾病等慢性疾病的盛行率不斷上升可能會推動細胞分析的需求。據美國癌症協會稱，預計 2024 年美國將診斷出超過 200 萬例新癌症病例。

細胞分析由於其應用範圍不斷擴大（從早期癌症診斷到癌症相關治療方法和工具的開發），在腫瘤學領域越來越受歡迎。從事腫瘤學領域的公司越來越關注細胞分析的進步，以開發先進的治療方法和療法。例如，2024 年 3 月，癌症診斷公司 Serum Detect 計劃在美國癌症研究協會 (AACR) 上展示其用於早期癌症檢測的 T 細胞分析方法。此類醫療保健公司將持續努力擴大細胞分析的應用，預計將在預測期內推動市場成長。

此外，細胞分析技術的進步推動了自動化細胞分析系統的開發，從而能夠提供更準確、更有效率的結果。同樣，自動細胞成像、細胞計數和細胞分選器等先進技術的發展使研究人員能夠更大規模地研究細胞。例如，2024 年 7 月。 NanoCellect Biomedical 宣布推出影像引導細胞分類機VERLO。細胞分選器可讓研究人員區分和分選相互作用的細胞，從而能夠精確表徵細胞亞群並檢驗其功能表現型，而不會破壞細胞相互作用。預計細胞分析技術的進步將在預測期內增加需求並推動市場成長。

除此之外，在藥物研發中採用細胞週期分析來分析所涉及的複雜性的情況顯著增加。同樣，細胞生物學、分子生物學、生物資訊學、蛋白質組學和基因組學的進步使得基於細胞的檢測在藥物開發過程中變得越來越重要。基於細胞的分析為傳統毒性和藥物安全性測試方法提供了一種替代方法，使研究人員能夠透過細胞毒性或細胞死亡在早期篩檢中識別有問題的測試化合物。因此，由於對先進療法的需求不斷成長而增加的藥物發現活動預計將增加對基於細胞的檢測的需求，從而推動市場成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章 蜂窩分析市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 細胞分析市場分析工具
    • 產業分析 – 波特五力分析
    • PESTEL 分析
    • COVID-19影響分析

第 4 章細胞分析市場：按產品/服務的估計和趨勢分析

  • 細分儀表板
  • 全球細胞分析市場產品與服務變化分析
  • 2018 年至 2030 年全球細胞分析材料市場規模及趨勢分析（依產品及服務）
  • 試劑和耗材
  • 裝置
  • 配件
  • 軟體
  • 服務

第 5 章細胞分析市場：依方法、估計和趨勢分析

  • 細分儀表板
  • 全球細胞分析市場方法變異分析
  • 2018 年至 2030 年全球細胞分析市場規模及趨勢分析（依方法）
  • 流式細胞技術
  • PCR
  • 細胞微陣列
  • 顯微鏡
  • 光強度
  • 進階內容篩檢
  • 其他

第6章 細胞分析材料市場：按製程分類的估計和趨勢分析

  • 細分儀表板
  • 全球細胞分析市場的製程變異性分析
  • 2018 年至 2030 年全球細胞分析市場規模及趨勢分析（依流程分類）
  • 細胞識別
  • 細胞活力
  • 細胞訊息傳遞路徑
  • 細胞增殖
  • 細胞計數
  • 細胞交互作用
  • 細胞結構研究
  • 單細胞分析
  • 其他

第 7 章細胞分析市場：最終用途、估計和趨勢分析

  • 細分儀表板
  • 全球細胞分析市場最終用途變化分析
  • 2018 年至 2030 年全球細胞分析市場規模及趨勢分析（依最終用途）
  • 製藥和生物技術公司
  • 醫院和臨床檢測實驗室
  • 學術研究所
  • 其他

第 8 章細胞分析市場：區域、估計與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 市場規模、預測趨勢分析，2018-2030
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024 年企業市場分析
  • 公司簡介/上市公司
    • Thermo Fisher Scientific, Inc.
    • Danaher
    • BD
    • Merck KGaA
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • Miltenyl BIoTech
    • Revvity
    • New England Biolabs
    • Avantor, Inc.
Product Code: GVR-4-68040-348-7

Cell Analysis Market Size & Trends:

The global cell analysis market size was estimated at USD 31.59 billion in 2024 and is projected to grow at a CAGR of 10.03% from 2025 to 2030. This growth can be attributed to the increasing prevalence of chronic diseases, advancements in cell analysis technologies, and the growing number of drug discovery activities. Cell analysis has emerged as an important tool for the identification of potential therapies and treatments for chronic diseases. Thus, the increasing prevalence of chronic diseases such as cardiovascular diseases, cancer, autoimmune diseases, neurological disorders, and others can drive the demand for cell analysis. According to the American Cancer Society, over 2 million new cancer cases are expected to be diagnosed in the U.S. in 2024.

Cell analysis has witnessed an increase in its application, from early-stage cancer diagnostics to the development of cancer-associated therapies and tools, which has further increased its popularity in the oncology sector. The players operating in the oncology sector are increasing their efforts for advancements in cell analysis to develop advanced therapies and treatments. For instance, in March 2024, a cancer diagnostics company, Serum Detect, was set to launch the T-cell analysis approach for early cancer detection at the American Association for Cancer Research (AACR). Such increasing efforts by healthcare companies to increase the application of cell analysis are anticipated to drive market growth over the forecast period.

Moreover, technological advancements in cell analysis have enabled the development of automated cell analysis systems that offer results with better accuracy and efficiency. Similarly, the development of advanced technologies such as automated cell imaging, cell counting, and cell sorters allows researchers to study cells on a much larger scale. For instance, in July 2024. NanoCellect Biomedical announced the launch of VERLO, an image-guided cell sorter. This cell-sorter allows the researchers to distinguish & sort interacting cells, enabling precise characterization of cell subsets & validation of their functional phenotypes without disturbing the cell interactions. Such advancements in cell analysis technologies are anticipated to increase demand and drive market growth over the forecast period.

In addition to this, the adoption of cell cycle analysis has significantly increased in drug discovery to analyze the associated complexities. Similarly, the increasing advancements in cell biology, molecular biology, bioinformatics, proteomics, and genomics have increased the significance of utilizing cell-based assays in the drug development process. Cell-based assays offer an alternative approach to the conventional methods of toxicity and drug safety testing and allow researchers to identify problems with tested compounds in early screening through cytotoxicity and cell deaths. Thus, the increasing drug discovery activities owing to the rising need for advanced treatments are anticipated to increase the demand for cell-based assays, thereby driving the market growth.

Global Cell Analysis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global cell analysis market report based on product & service, technique, process, end-use, and region.

  • Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
  • Reagents & Consumables
  • Instruments
  • Accessories
  • Software
  • Service
  • Technique Outlook (Revenue, USD Million, 2018 - 2030)
  • Flow Cytometry
  • PCR
  • Cell Microarrays
  • Microscopy
  • Spectrophotometry
  • High Content-Screening
  • Other Techniques
  • Process Outlook (Revenue, USD Million, 2018 - 2030)
  • Cell Identification
  • Cell Viability
  • Cell Signaling Pathways
  • Cell Proliferation
  • Cell Counting
  • Cell Interaction
  • Cell Structure Study
  • Single-cell Analysis
  • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinical Testing Laboratories
  • Academic & Research Institutes
  • Other
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service Segment
    • 1.2.2. Technique Segment
    • 1.2.3. Process Segment
    • 1.2.4. End use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Cell Analysis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Advancements in cell analysis technologies
      • 3.2.1.3. Growing number of drug discovery activities
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Complexity of cell analysis techniques
  • 3.3. Cell Analysis Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Cell Analysis Market: Product & Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Cell Analysis Market Product & Service Movement Analysis
  • 4.3. Global Cell Analysis Materials Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Reagents & Consumables
    • 4.4.1. Reagents & Consumables market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Instruments
    • 4.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Accessories
    • 4.6.1. Accessories market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Software
    • 4.7.1. Software market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Service
    • 4.8.1. Service market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Cell Analysis Market: Technique Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Cell Analysis Market Technique Movement Analysis
  • 5.3. Global Cell Analysis Materials Market Size & Trend Analysis, by Technique, 2018 to 2030 (USD Million)
  • 5.4. Flow Cytomtery
    • 5.4.1. Flow Cytomtery market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. PCR
    • 5.5.1. PCR market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Cell Microarrays
    • 5.6.1. Cell Microarrays market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Microscopy
    • 5.7.1. Microscopy market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Spectrophotometry
    • 5.8.1. Spectrophotometry market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. High Content-Screening
    • 5.9.1. High Content-Screening market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.10. Other Techniques
    • 5.10.1. Other Techniques market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Cell Analysis Materials Market: Process Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Cellular Starting Materials Market Process Movement Analysis
  • 6.3. Global Cellular Starting Materials Market Size & Trend Analysis, by Process, 2018 to 2030 (USD Million)
  • 6.4. Cell Identification
    • 6.4.1. Cell Identification market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Cell Viability
    • 6.5.1. Cell Viability market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Cell Signaling Pathways
    • 6.6.1. Cell Signaling Pathwaysmarket estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Cell Proliferation
    • 6.7.1. Cell Proliferation market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Cell Counting
    • 6.8.1. Cell Counting market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. Cell Interaction
    • 6.9.1. Cell Interaction market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.10. Cell Structure Study
    • 6.10.1. Cell Structure Study market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.11. Single-cell Analysis
    • 6.11.1. Single-cell Analysis market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.12. Others
    • 6.12.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Cellular Starting Materials Market: End use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Cellular Starting Materials Market End use Movement Analysis
  • 7.3. Global Cellular Starting Materials Market Size & Trend Analysis, by End use, 2018 to 2030 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology Companies
    • 7.4.1. Pharmaceutical & Biotechnology Companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Hospitals & Clinical Testing Laboratories
    • 7.5.1. Hospitals & Clinical Testing Laboratories market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Academic & Research Institutes
    • 7.6.1. Academic & Research Institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Other
    • 7.7.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Cell Analysis Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. Target disease prevalence
      • 8.4.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Target disease prevalence
      • 8.4.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Competitive scenario
      • 8.4.4.3. Regulatory framework
      • 8.4.4.4. Target disease prevalence
      • 8.4.4.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. Target disease prevalence
      • 8.5.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. Target disease prevalence
      • 8.5.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. Target disease prevalence
      • 8.5.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Target disease prevalence
      • 8.5.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Regulatory framework
      • 8.5.6.4. Target disease prevalence
      • 8.5.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Regulatory framework
      • 8.5.7.4. Target disease prevalence
      • 8.5.7.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Competitive scenario
      • 8.5.8.3. Regulatory framework
      • 8.5.8.4. Target disease prevalence
      • 8.5.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.9. Denmark
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Competitive scenario
      • 8.5.9.3. Regulatory framework
      • 8.5.9.4. Target disease prevalence
      • 8.5.9.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. Target disease prevalence
      • 8.6.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. Target disease prevalence
      • 8.6.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Competitive scenario
      • 8.6.4.3. Regulatory framework
      • 8.6.4.4. Target disease prevalence
      • 8.6.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Competitive scenario
      • 8.6.5.3. Regulatory framework
      • 8.6.5.4. Target disease prevalence
      • 8.6.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Competitive scenario
      • 8.6.6.3. Regulatory framework
      • 8.6.6.4. Target disease prevalence
      • 8.6.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Competitive scenario
      • 8.6.7.3. Target disease prevalence
      • 8.6.7.4. Regulatory framework
      • 8.6.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Target disease prevalence
      • 8.7.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Competitive scenario
      • 8.7.3.3. Regulatory framework
      • 8.7.3.4. Target disease prevalence
      • 8.7.3.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Competitive scenario
      • 8.8.2.3. Regulatory framework
      • 8.8.2.4. Target disease prevalence
      • 8.8.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Competitive scenario
      • 8.8.3.3. Regulatory framework
      • 8.8.3.4. Target disease prevalence
      • 8.8.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Competitive scenario
      • 8.8.4.3. Regulatory framework
      • 8.8.4.4. Target disease prevalence
      • 8.8.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key country dynamics
      • 8.8.5.2. Competitive scenario
      • 8.8.5.3. Regulatory framework
      • 8.8.5.4. Target disease prevalence
      • 8.8.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Thermo Fisher Scientific, Inc.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Danaher
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. BD
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Merck KGaA
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Agilent Technologies, Inc.
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Bio-Rad Laboratories, Inc.
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Miltenyl Biotech
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Revvity
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. New England Biolabs
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Avantor, Inc.
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global cell analysis market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 4 Global cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 5 Global cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 6 Global cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 North America cell analysis market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 9 North America cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 10 North America cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 11 North America cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 U.S. cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 13 U.S. cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 14 U.S. cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 15 U.S. cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Canada cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 17 Canada cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 18 Canada cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 19 Canada cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Mexico cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 21 Mexico cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 22 Mexico cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 23 Mexico cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Europe cell analysis market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 26 Europe cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 27 Europe cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 28 Europe cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Germany cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 30 Germany cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 31 Germany cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 32 Germany cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 UK cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 34 UK cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 35 UK cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 36 UK cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 France cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 38 France cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 39 France cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 40 France cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Italy cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 42 Italy cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 43 Italy cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 44 Italy cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Spain cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 46 Spain cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 47 Spain cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 48 Spain cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Denmark cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 50 Denmark cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 51 Denmark cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 52 Denmark cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Sweden cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 54 Sweden cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 55 Sweden cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 56 Sweden cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Norway cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 58 Norway cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 59 Norway cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 60 Norway cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific cell analysis market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 China cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 67 China cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 68 China cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 69 China cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 Japan cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 71 Japan cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 72 Japan cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 73 Japan cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 India cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 75 India cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 76 India cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 77 India cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 South Korea cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 79 South Korea cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 80 South Korea cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 81 South Korea cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Australia cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 83 Australia cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 84 Australia cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 85 Australia cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Thailand cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 87 Thailand cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 88 Thailand cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 89 Thailand cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 Latin America cell analysis market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 92 Latin America cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 93 Latin America cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 94 Latin America cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Brazil cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 96 Brazil cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 97 Brazil cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 98 Brazil cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Argentina cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 100 Argentina cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 101 Argentina cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 102 Argentina cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 103 MEA cell analysis market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 105 MEA cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 106 MEA cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 107 MEA cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 108 South Africa cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 109 South Africa cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 110 South Africa cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 111 South Africa cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 UAE cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 117 UAE cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 118 UAE cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 119 UAE cell analysis market, by end-use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 121 Kuwait cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 122 Kuwait cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 123 Kuwait cell analysis market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Cell Analysis market: Market outlook
  • Fig. 5 Cell Analysis market: Segment outlook
  • Fig. 6 Cell Analysis market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Cell Analysis market driver impact
  • Fig. 9 Cell Analysis market restraint impact
  • Fig. 10 Cell Analysis market: Product & Service outlook and key takeaways
  • Fig. 11 Cell Analysis market: Product & Service movement analysis
  • Fig. 12 Reagents & consumables market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Accessories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Software market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Service market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Cell Analysis market: Technique outlook and key takeaways
  • Fig. 18 Cell Analysis market: Technique movement analysis
  • Fig. 19 Flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Cell microarrays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Microscopy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Spectrophotometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 High content-screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Other techniques market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Cell Analysis market: Process outlook and key takeaways
  • Fig. 27 Cell Analysis market: Process movement analysis
  • Fig. 28 Cell identification market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Cell viability market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Cell Signaling Pathwaysmarket estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Cell proliferation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Cell counting market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Cell interaction market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Cell structure study market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Cell Analysis market: End use outlook and key takeaways
  • Fig. 38 Cell Analysis market: End use movement analysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Hospitals & clinical testing laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Other market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Global Cell Analysis market: Regional outlook and key takeaways
  • Fig. 44 Global Cell Analysis market: Regional movement analysis
  • Fig. 45 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Target Disease Prevalence
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Target Disease Prevalence
  • Fig. 52 Key country dynamics
  • Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Target Disease Prevalence
  • Fig. 55 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Target Disease Prevalence
  • Fig. 59 Key country dynamics
  • Fig. 60 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Target Disease Prevalence
  • Fig. 62 Key country dynamics
  • Fig. 63 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Target Disease Prevalence
  • Fig. 65 Key country dynamics
  • Fig. 66 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Target Disease Prevalence
  • Fig. 68 Key country dynamics
  • Fig. 69 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Target Disease Prevalence
  • Fig. 71 Key country dynamics
  • Fig. 72 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Target Disease Prevalence
  • Fig. 74 Key country dynamics
  • Fig. 75 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Target Disease Prevalence
  • Fig. 77 Key country dynamics
  • Fig. 78 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Target Disease Prevalence
  • Fig. 80 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Target Disease Prevalence
  • Fig. 84 Key country dynamics
  • Fig. 85 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Target Disease Prevalence
  • Fig. 87 Key country dynamics
  • Fig. 88 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Target Disease Prevalence
  • Fig. 90 Key country dynamics
  • Fig. 91 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Target Disease Prevalence
  • Fig. 93 Key country dynamics
  • Fig. 94 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Target Disease Prevalence
  • Fig. 96 Key country dynamics
  • Fig. 97 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Target Disease Prevalence
  • Fig. 99 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Target Disease Prevalence
  • Fig. 103 Key country dynamics
  • Fig. 104 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Target Disease Prevalence
  • Fig. 106 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 109 Target Disease Prevalence
  • Fig. 110 Key country dynamics
  • Fig. 111 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 112 Target Disease Prevalence
  • Fig. 113 Key country dynamics
  • Fig. 114 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 115 Target Disease Prevalence
  • Fig. 116 Key country dynamics
  • Fig. 117 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 118 Target Disease Prevalence